Tactile Systems Technology Inc

This committee controls taxation, trade, and entitlement spending (Medicare/Medicaid). Its decisions on corporate tax policy directly affect profitability, trade policy can impact supply chains or international sales, and, most critically, its influence over Medicare/Medicaid directly impacts reimbursement rates and demand for medical devices for a large segment of the population.

This committee allocates discretionary federal spending. Its subcommittees determine the precise funding for various federal programs, including those related to healthcare (e.g., NIH research, VA services, Medicare/Medicaid administrative budgets), directly impacting the purchasing power of key customers and funding for medical research relevant to the industry.

This committee has direct oversight over the FDA, which is the primary regulatory body for medical device approval and safety. It also influences NIH funding for medical research and labor laws, all of which directly and significantly impact Tactile Systems Technology's operations, product development, and market access.

This committee oversees intellectual property (IP) laws and antitrust enforcement. For a medical instrument manufacturer, strong IP protection (patents) is crucial for innovation and market exclusivity. Antitrust reviews are also critical for potential mergers and acquisitions in the industry.

This committee oversees the Department of Veterans Affairs (VA). As a medical device manufacturer, Tactile Systems Technology could be a supplier to the VA healthcare system. Decisions on VA funding and healthcare programs directly impact a significant government customer and the demand for medical instruments.